John Podhoretz Nukes Jennifer Rubin FROM ORBIT for Claiming Hitler Is LITERALLY in...
MSNBC Celebrates Beating CNN in Election Night Ratings (Guess Why So Many Were...
Oh HELL YEAH! Trump Shares EPIC, Kick-Butt, Super RAD 10-Step Plan to DISMANTLE...
Of ALL the Groups Kamala Lost, the 1 She BARELY Kept By 1...
'You're SUPER Emotional': Scott Jennings Leaves TDS-Comedian SPEECHLESS in Back and Forth...
#SocialMediaVideoCritique: Justine Bateman Offers HILARIOUS Film Tips to Melting Down TikT...
WATCH: Michael Cohen Getting Turkey-Trolled Might Be the FUNNIEST Thing You See Today
WATCH: Jews Under Attack in Amsterdam While the Legacy Media is Silent
TRUMP 47 SALE: 74% Off VIP Membership - FINAL HOURS!
Desperate Dem's Latest Far-Fetched Fantasy: Supreme Court Justice Kamala Harris - YES, REA...
Enjoy This Photo of Two Women Failed by America and Beaten by Trump
Psycho Says She's Purchasing a Glock and Shooting Every White Man She Sees
The Most Misogynistic President Ever Just Appointed the First Woman Chief of Staff...
Republican Against Trump Doesn’t Want the Stain of the Party Anymore
Jess Piper Suggests Anti-Trump White Women Get Identifying Tattoos

Christina Pushaw busts the AP for acknowledging a COVID treatment fact they shamed Ron DeSantis for pointing out just a few months ago

Yesterday, the Associated Press’ Matthew Perrone reported a possible setback for a couple of COVID19 treatments, including Regeneron.

Advertisement

More from the AP:

As strained U.S. hospitals brace for a new surge of COVID-19 cases caused by the fast-spreading omicron variant, doctors are warning of yet another challenge: the two standard drugs they’ve used to fight infections are unlikely to work against the new strain.

For more than a year antibody drugs from Regeneron and Eli Lilly have been the go-to treatments for early COVID-19, thanks to their ability to head off severe disease and keep patients out of the hospital.

But both drugmakers recently warned that laboratory testing suggests their therapies will be much less potent against omicron, which contains dozens of mutations that make it harder for antibodies to attack the virus. And while the companies say they can quickly develop new omicron-targeting antibodies, those aren’t expected to launch for at least several months.

The fact that Regeneron may not be as effective against the omicron variant as it’s been against others is noteworthy enough. But Gov. Ron DeSantis’ press secretary Christina Pushaw finds something else noteworthy, too:

Things sure have changed, haven’t they? Recall this past August, when the AP was entertaining the idea that DeSantis was promoting sketchy Regeneron in some kind of quid pro quo scheme because one of his top donors had invested money in Regeneron, making DeSantis shady AF and not to be trusted.

Advertisement

Pushaw called out the AP then.

Just like she’s calling out the AP now.

We’ve got whiplash.

And Pushaw’s got one last question for the AP:

Join the conversation as a VIP Member

Recommended

Trending on Twitchy Videos

Advertisement
Advertisement
Advertisement